4//SEC Filing
BAKER DOUGLAS P 4
Accession 0001213900-21-048250
CIK 0001448431other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:45 PM ET
Size
4.6 KB
Accession
0001213900-21-048250
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
BAKER DOUGLAS P
Chief Financial Officer
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-09-14$65.57/sh−3,768$247,068→ 44,796 total
Footnotes (1)
- [F1]These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001028775
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:45 PM ET
- Size
- 4.6 KB